DentalCare Logo

Oral Cancer

Course Number: 348

References / Additional Resources

  1. Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis. 2021 Nov;27(8):1947-1976. doi: 10.1111/odi.13993. Epub 2021 Sep 14. PMID: 34418233.

  2. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008 Jul;9(7):667-75. doi: 10.1016/S1470-2045(08)70173-6. PMID: 18598931.

  3. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008 Jan;44(1):10-22. doi: 10.1016/j.oraloncology.2007.06.011. Epub 2007 Sep 6. PMID: 17825602; PMCID: PMC2424250.

  4. Belcher R, Hayes K, Fedewa S, Chen AY. Current treatment of head and neck squamous cell cancer. J Surg Oncol. 2014 Oct;110(5):551-74. doi: 10.1002/jso.23724. Epub 2014 Jul 23. PMID: 25053506.

  5. Wong HM. Oral complications and management strategies for patients undergoing cancer therapy. ScientificWorldJournal. 2014 Jan 8;2014:581795. doi: 10.1155/2014/581795. PMID: 24511293; PMCID: PMC3910370.

  6. Carl W. Oral complications of local and systemic cancer treatment. Curr Opin Oncol. 1995 Jul;7(4):320-4.

  7. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004 Dec;31(6):744-54.

Additional References